Risk factors for developing endometrial cancer after benign endometrial sampling

Area of Science:

• Gynecologic Oncology
• Cancer Epidemiology
• Reproductive Health

Background:

• A significant proportion of endometrial cancer cases arise after initial benign findings on endometrial biopsy or dilation and curettage (D&C).
• Identifying specific risk factors is crucial for targeted screening and prevention strategies in this patient population.

Purpose of the Study:

• To determine the risk factors associated with developing endometrial cancer following a diagnosis of benign endometrial biopsy or D&C results.
• To identify protective factors against endometrial cancer in women with prior non-atypical endometrial findings.

Main Methods:

• A nested case-control study utilized data from the Rochester Epidemiology Project.
• 90 patients with endometrial cancer and prior benign endometrial biopsy/D&C were compared to 172 matched controls with benign results and no subsequent cancer.

Main Results:

• Personal history of colorectal cancer, endometrial polyps, and morbid obesity were independently associated with increased endometrial cancer risk.
• Oral contraceptive pill (OCP) use demonstrated a significant protective effect (OR 0.18).
• The presence of one or more risk factors substantially increased the risk of endometrial cancer, conferring a lifetime risk of 18% to 32%.

Conclusions:

• Approximately 24.5% of endometrial cancer patients had prior benign endometrial biopsy or D&C results.
• Endometrial polyps, history of colorectal cancer, and morbid obesity are key risk factors.
• OCP use is the strongest identified protective factor against endometrial cancer in this context.